EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A catechol-modified quaternized chitosan/PEG hydrogel for diabetic wound healing: synergistic effects of TGF-β3 delivery, angiogenesis, and antibacterial activity

Xiu Yang, Zheng-Chao Zhang, Bo Liu, Yu-Nan Lu, Xue-Yi He, Hui-Dong Chen, Jia-Xun Yang, Jia-Yu He, Yi-Ren Zhu, Chang-Li Huang, Wu-Bing He

Frontiers in Cellular and Infection Microbiology · 2025

DOI: 10.3389/fcimb.2025.1717082 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2025. Verfasst von Xiu Yang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Shengli Clinical Medical College of Fujian Medical University, Fuzhou, China. Hauptthemen laut MEDLINE: Chitosan, Anti-Bacterial Agents, Wound Healing, Transforming Growth Factor beta3. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Diabetic foot ulcers (DFUs) represent a challenging chronic wound model, often plagued by biofilm formation that sustains inflammation and impedes healing. Transforming growth factor-beta 3 (TGF-β3) is a promising cytokine for tissue regeneration, yet its delivery within the hostile, infected wound milieu remains problematic. This study addresses the intertwined challenges of microbial resistance and healing impairment by developing a multifunctional injectable hydrogel that couples inherent antibacterial activity with sustained TGF-β3 release.

Methods

A catechol-modified quaternized chitosan (QCS-Catechol) was synthesized and crosslinked with benzaldehyde-terminated 4-arm polyethylene glycol (4-arm PEG-CHO) to form the BP-QS/TGF-β3 hydrogel. Its physicochemical properties, injectability, adhesion, and mechanical strength were characterized. Antibacterial efficacy was evaluated against Staphylococcus aureus and Escherichia coli . The biocompatibility and therapeutic potential of the BP-QS/TGF-β3 hydrogel were evaluated through in vitro assays (CCK-8, apoptosis, hemolysis) and in a streptozotocin-induced diabetic mouse model, respectively, against controls including PBS, BP-QS (blank hydrogel), and free TGF-β3 solution. Wound closure kinetics, histology (H&E, Masson’s trichrome), and immunohistochemistry (CD31, Ki-67) were analyzed.

Results

The BP-QS/TGF-β3 hydrogel demonstrated rapid gelation (~3 min), excellent injectability, robust tissue adhesion (28.5 ± 2.1 J/m²), and suitable mechanical properties. It exhibited outstanding biocompatibility and potent, broad-spectrum antibacterial efficiency (>94%). The sustained release of TGF-β3 significantly enhanced fibroblast migration and proliferation in vitro . In diabetic mice, the BP-QS/TGF-β3 treatment achieved the most rapid wound closure, with the lowest relative wound deficit (7.30% ± 2.76% on day 12), significantly outperforming the PBS control, BP-QS hydrogel, and free TGF-β3 solution groups (p < 0.01). Histological analyses revealed enhanced granulation tissue formation, collagen deposition (724.61 ± 60.12 μm), angiogenesis, and cell proliferation. No systemic toxicity was observed.

Conclusions

The BP-QS/TGF-β3 hydrogel synergizes potent antibacterial action with sustained TGF-β3 delivery to disrupt the vicious cycle of biofilm infection and healing failure. This integrated, multidisciplinary strategy effectively targets the core pathology of diabetic wounds, offering a promising therapeutic platform for managing biofilm-infected chronic wounds.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ChitosanAnti-Bacterial AgentsWound HealingTransforming Growth Factor beta3HydrogelsPolyethylene GlycolsCatecholsDiabetic FootAnimalsMiceEscherichia coliStaphylococcus aureusMaleDiabetes Mellitus, ExperimentalDisease Models, AnimalNeovascularization, PhysiologicHumansAngiogenesis

Stichwörter der Autor:innen

TGF-β3angiogenesisantibacterial effectdiabetic wound healinghydrogelquaternized chitosansustained release

Substanzen

ChitosanAnti-Bacterial AgentsTransforming Growth Factor beta3HydrogelsPolyethylene GlycolsCatecholscatechol

Autor:innen und Institutionen

  • Shengli Clinical Medical College of Fujian Medical University, Fuzhou, China.
  • Fuzong Clinical Medical College of Fujian Medical University, Fuzhou, China.
  • Fuzhou University Affiliated Provincial Hospital, Fuzhou, Fujian, China.
  • Department of Emergency Trauma Surgery, Fujian Trauma Medicine Center, Fujian Key Laboratory of Emergency Medicine, Fujian Provincial Hospital, Fuzhou, China.

Zitieren

APA

Yang, X., Zhang, Z. C., Liu, B., Lu, Y. N., He, X. Y., Chen, H. D., Yang, J. X., He, J. Y., Zhu, Y. R., Huang, C. L., & He, W. B. (2025). A catechol-modified quaternized chitosan/PEG hydrogel for diabetic wound healing: synergistic effects of TGF-β3 delivery, angiogenesis, and antibacterial activity. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2025.1717082

Vancouver

Yang X, Zhang ZC, Liu B, Lu YN, He XY, Chen HD, et al. A catechol-modified quaternized chitosan/PEG hydrogel for diabetic wound healing: synergistic effects of TGF-β3 delivery, angiogenesis, and antibacterial activity. Frontiers in Cellular and Infection Microbiology. 2025. doi:10.3389/fcimb.2025.1717082

BibTeX
@article{Yang2025,
  author = {Yang, Xiu and Zhang, Zheng-Chao and Liu, Bo and Lu, Yu-Nan and He, Xue-Yi and Chen, Hui-Dong and Yang, Jia-Xun and He, Jia-Yu and Zhu, Yi-Ren and Huang, Chang-Li and He, Wu-Bing},
  title = {A catechol-modified quaternized chitosan/PEG hydrogel for diabetic wound healing: synergistic effects of TGF-β3 delivery, angiogenesis, and antibacterial activity},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2025},
  doi = {10.3389/fcimb.2025.1717082}
}
Kostenlos starten →